-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FTjwTG47Q1FWYsGXP4QQvk3EwuWL7ytbkreF8SAvwZtDQV2Syj8mKs5yJxMLjGAY Eesm5p6D+fG2JGmXjRS48g== 0001140361-07-003136.txt : 20070213 0001140361-07-003136.hdr.sgml : 20070213 20070213075755 ACCESSION NUMBER: 0001140361-07-003136 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070209 FILED AS OF DATE: 20070213 DATE AS OF CHANGE: 20070213 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DOR BIOPHARMA INC CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1101 BRICKELL AVENUE STREET 2: SUITE 701 S CITY: MIAMI STATE: FL ZIP: 33131 BUSINESS PHONE: 305-534-3383 MAIL ADDRESS: STREET 1: 1101 BRICKELL AVENUE STREET 2: SUITE 701 S CITY: MIAMI STATE: FL ZIP: 33131 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MYRIANTHOPOULOS EVAN CENTRAL INDEX KEY: 0001050955 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16929 FILM NUMBER: 07605929 BUSINESS ADDRESS: STREET 1: DISCOVERY LABORATORIES INC STREET 2: 509 MADISON AVE 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2122234504 MAIL ADDRESS: STREET 2: 509 MADISON AVE 14TH FL CITY: NEW YORK STATE: NY ZIP: 10022 4 1 doc1.xml FORM 4 X0202 4 2007-02-09 0 0000812796 DOR BIOPHARMA INC DOR 0001050955 MYRIANTHOPOULOS EVAN 1101 BRICKELL AVENUE SUITE 701-S MIAMI FL 33131 1 1 0 0 Chief Financial Officer Common Stock 2007-02-09 2007-02-09 4 P 0 53191 0.47 A 154817 D Stock Options (right to buy) .47 2004-11-10 2014-11-10 Common Stock 150000 150000 D Stock Options (right to buy) .58 2004-09-09 2014-09-09 Common stock 50000 50000 D Stock Options (right to buy) .90 2003-09-15 2013-09-15 Common Stock 50000 50000 D Stock Warrants (right to buy) .8756 2003-09-15 2008-09-15 Common Stock 120888 120888 D Stock Warrants (right to buy) .35 2002-12-30 2007-12-30 Common Stock 43929 43929 D Stock Warrants (right to buy) .75 2002-12-30 2007-12-30 Common Stock 21525 21525 D Stock Options (righ to buy) .35 2002-11-14 2012-11-14 Common Stock 150000 150000 D Stock Options (right to buy) .49 2004-12-13 2014-12-13 Common Stock 500000 500000 D Stock Warrants (right to buy) .246 2006-04-10 2016-04-10 Common Stock 90220 90220 D Stock Options (right to buy) 0.35 2006-05-10 2016-05-10 Common Stock 400000 400000 D Private purchase of common stock as part of February 2007 PIPE. Exercise price changed from 0.45 to 0.246 due to dilutive event occurring on shares issued in Sigma Tau financing also, 11,369 additional shares were issued /s/ Evan Myrianthopoulos 2007-02-09 -----END PRIVACY-ENHANCED MESSAGE-----